2021
DOI: 10.1016/j.ijid.2021.06.006
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence of high-risk human papillomavirus infection among Kazakhstani women attending gynecological outpatient clinics

Abstract: To conduct a nationwide high-risk human papillomavirus (HR-HPV) infection genotyping analysis of women attending gynecological clinics and identify factors associated with HR-HPV infection. Methods: A cross-sectional survey-based study with 759 participants. Demographics, lifestyle, and medical history data were collected by questionnaire completed by gynecologists during patients' visits. Cervical swabs were used for HPV genotyping using AmpliSens kit. Data analysis included descriptive statistics consisting … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
12
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 16 publications
(14 citation statements)
references
References 33 publications
(46 reference statements)
1
12
1
Order By: Relevance
“…Thus, this is the first study that aimed to examine attitudes toward HPV vaccination and explore factors associated with a positive attitude toward HPV vaccination in Kazakhstani women. Since HR-HPV prevalence is high among women in Kazakhstan [ 13 , 14 , 15 , 21 ], and cervical cancer incidence has increased in the past decade [ 16 ], becoming the fourth leading cause of death from cancer among women [ 35 ], it is important to implement primary prevention of HPV infection and its related diseases in the country. However, the successful relaunching of the HPV vaccination program largely depends on HPV vaccine attitudes; therefore, studies investigating society’s attitudes towards the vaccine are an essential part of facilitating the process.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Thus, this is the first study that aimed to examine attitudes toward HPV vaccination and explore factors associated with a positive attitude toward HPV vaccination in Kazakhstani women. Since HR-HPV prevalence is high among women in Kazakhstan [ 13 , 14 , 15 , 21 ], and cervical cancer incidence has increased in the past decade [ 16 ], becoming the fourth leading cause of death from cancer among women [ 35 ], it is important to implement primary prevention of HPV infection and its related diseases in the country. However, the successful relaunching of the HPV vaccination program largely depends on HPV vaccine attitudes; therefore, studies investigating society’s attitudes towards the vaccine are an essential part of facilitating the process.…”
Section: Discussionmentioning
confidence: 99%
“…The lowest prevalence of HPV infection is reported in Middle Eastern and North African countries (7–16%) [ 12 ]. According to the available epidemiological data, HR-HPV prevalence in Kazakhstan is high among women attending gynecological offices, ranging from 39% to 43% [ 13 , 14 , 15 ].…”
Section: Introductionmentioning
confidence: 99%
“…Existing studies show mixed relationships of various demographic, socioeconomic, and behavioral risk factors with STIs, mostly with the clinical outcomes, such as chlamydia, gonorrhea, genital herpes, syphilis, and trichomoniasis [15][16][17][18][19][20][21]. For example, some population-level studies from low-income countries find that women with lower social status (e.g., lower levels of education, lower income, etc.)…”
Section: Introductionmentioning
confidence: 99%
“…Studies have also shown that women who encountered spousal abuse were significantly more likely to report STIs [17][18][19]. Younger age [15,16], being married [23], and contraceptives use [18] were associated with increased STIs. Further, women who solely took decisions about own healthcare were less likely to report STI [17].…”
Section: Introductionmentioning
confidence: 99%
“…Previous evidence has found that in developing countries, women under 25 years of age and women over 50 years of age exhibit high rates of HR-HPV infection, whereas women between 25 and 50 years of age have lower rates. [5][6][7][8] HPV vaccination is the most effective way to prevent cervical cancer, but China's HPV vaccine was only first licensed in 2016, 9 and the coverage rate is low. Therefore, it is very important to improve our current screening system.…”
Section: Introductionmentioning
confidence: 99%